Altamira Therapeutics Market Cap

Altamira Therapeutics has a market cap or net worth of $347.09 thousand as of March 31, 2025. Its market cap has decreased by -88.24% in one year.

Market Cap

347.09K

Enterprise Value

709.07K

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.07

Market Cap Chart

Since August 8, 2014, Altamira Therapeutics's market cap has decreased from 171.70M to 347.09K, a decrease of -99.80%. That is a compound annual growth rate of -44.17%.

Market Cap History

Date	Market Cap	% Change
Mar 28, 2025	347.09K	-7.66%
Dec 31, 2024	375.87K	-72.84%
Dec 29, 2023	1.38M	-75.59%
Dec 30, 2022	5.67M	-78.93%
Dec 31, 2021	26.91M	-10.02%
Dec 31, 2020	29.91M	459.11%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.93B
SS Innovations International	1.76B
Nika Pharmaceuticals	1.02B
Veradigm	686.79M
Elite Pharmaceuticals	502.09M
Glass House Brands	373.34M
Northwest Biotherapeutics	325.57M
CytoDyn	294.42M

Market Cap Rankings